NNZ 2591

MedChem Express

NNZ 2591

10

Research Use Only

99.98

NNZ 2591 is a synthetic analogue of a small peptide of cyclic glycine proline (cGP). NNZ 2591 shows orally active and cross the blood-brain barrier. NNZ 2591 shows neuroprotective after ischemic brain injury. NNZ 2591 improves motor function in a rat model of Parkinsons disease. NNZ 2591 has the potential for the research of ischemic brain injury and angelman syndrome[1][2][3].

-20°C,2°C to 8°C

12352202